All News

New Rx, generics, and OTC

A Kentucky pharmacy will pay $9.25 million to resolve allegations it received kickbacks from a manufacturer for recommending physicians prescribe a certain drug.

ASHP has urged FDA to create a centralized electronic system for all Risk Evaluation and Mitigation Strategy programs.

In April 2015, FDA approved Ivabradine to reduce the risk of hospitalizations due to worsening heart failure in indicated patients.

As existential questions go, it's a big one for pharmacists. Here's Dennis Miller's answer.

Humira (adalimumab) and Enbrel (etanercept) accounted for the largest number of injury reports received by the FDA last year, according to a new edition of the Institute for Safe Medication Practices’ (ISMP) QuarterWatch.

The National Community Pharmacists Association (NCPA) holds its annual convention at the Gaylord National Resort & Convention Center, National Harbor, Md., this Saturday, Oct. 10 through Wednesday, Oct. 14, with opportunities to network/socialize, share great ideas, and learn.

PQA, VoicePort, and Scientific Technologies are collaborating on ImmuSMART, the Immunization Services Model for Adult Rate Improvement project.

St. Louis College of Pharmacy has partnered with Washington University School of Medicine, both located in St. Louis, to create the Center for Clinical Pharmacology to research new approaches for pain relief including new analgesics and other therapeutic ways to manage chronic pain.

Following the lead of its competitor Walgreens, CVS has installed time-delayed safes in its pharmacies in the Indianapolis area in an effort to curb the increasing number of pharmacy robberies there.

If you want improved working conditions in the pharmacy, you're gonna hafta help.

The answer, it turns out, is "Plenty." Just ask Topeka Pharmacy's Tom and Morag Miller.

In perhaps what is a disturbing sign of the times, a 12-year-old was recently arrested for attempting to rob a Walgreens in Indianapolis, according to a report in the Indianapolis Star.

An affiliate of Northeast Ohio Medical University and Ritzman Pharmacy of Wadsworth, OH. are working together to create a “pharmacy of the future” that is scheduled to open in January.

First of all, take a tip from The Hitchhiker's Guide: Don't panic.

The off-label use of tramadol in children following surgery may be problematic and healthcare professionals should consider other FDA-approved drugs for pain relief, according to a FDA safety communication.

FDA has approved two long-acting insulins by Novo Nordisk for the treatment of adults with diabetes mellitus.

How a large healthcare system in St. Louis, Mo., drove down the number of severe hypoglycemia cases in hospitalized patients over a five-year period.

FDA has approved a combination oral therapy of trifluridine and tipiracil (Lonsurf, Taiho Oncology) for patients with metastatic colorectal cancer who were previously treated with chemotherapy and biological therapy.

Naloxone is now available without a prescription at CVS pharmacies in 14 states, the company recently announced.

Pharmacy workers in Target’s Brooklyn, NY-based store have voted to form a microunion, becoming the first pharmacy in the retail giant’s history to unionize.

A California appeals court has upheld the California Board of Pharmacy’s discipline against a pharmacist who supervised a pharmacy technician who stole more than $1 million worth of painkillers.

Following public outrage over price increases for two specialty drugs, the frontrunners for the Democratic nomination for president are both pushing plans to lower the costs of prescription drugs.

The U.S. House of Representatives recently passed legislation reauthorizing a federal program that provides grants to help states create and use prescription drug monitoring programs.

U.S. Senators Amy Klobuchar (D-Minn.) and Chuck Grassley (R-Iowa) recently reintroduced legislation that would make it illegal for brand-name drug manufacturers to pay-off other drug manufacturers to keep generic versions of brand-name drugs off the market.

ASHP has contracted with FDA to develop and implement national standardized concentrations for intravenous and oral liquid medications.

FDA has approved cariprazine (Vraylar) capsules, an atypical antipsychotic, indicated for the treatment of adults with schizophrenia as well as bipolar I disorder, based on controlled trials of more than 2,700 individuals.

While healthcare providers agree that mobile health apps can reduce healthcare costs and improve patient outcomes, a few barriers to full adoption remain, according to a new report.